[Clinical pharmacology of sodium nitroprusside].
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders; D004285:Dogs; D005292:Ferricyanides / Q000494:pharmacology*; D006801:Humans; D007023:Hypotension, Controlled; D009599:Nitroprusside / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D014150:Antipsychotic Agents; D005292:Ferricyanides; D009599:Nitroprusside
Pharmacologie clinique du nitroprussiate de sodium.